CRVS logo

Corvus Pharmaceuticals (CRVS) Company Overview

Profile

Full Name:

Corvus Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 23, 2016

Indexes:

Not included

Description:

Corvus Pharmaceuticals is a biopharmaceutical company focused on developing innovative cancer treatments. They work on new therapies that target the immune system to fight cancer more effectively. Their goal is to improve patient outcomes and provide better options for those affected by cancer.

Events Calendar

Earnings

Next earnings date:

Mar 19, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 19, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 14, 25 HC Wainwright & Co.
Buy
Jan 2, 25 HC Wainwright & Co.
Buy
Nov 13, 24 Oppenheimer
Outperform
Sep 16, 24 Ladenburg Thalmann
Buy
May 7, 24 Oppenheimer
Outperform
Apr 1, 24 Cantor Fitzgerald
Overweight
Mar 27, 24 Mizuho
Neutral
Mar 20, 24 Oppenheimer
Outperform
Sep 7, 23 Cantor Fitzgerald
Overweight
Jun 16, 23 Mizuho
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Corvus Pharmaceuticals?
  • Does Corvus Pharmaceuticals pay dividends?
  • What sector is Corvus Pharmaceuticals in?
  • What industry is Corvus Pharmaceuticals in?
  • What country is Corvus Pharmaceuticals based in?
  • When did Corvus Pharmaceuticals go public?
  • Is Corvus Pharmaceuticals in the S&P 500?
  • Is Corvus Pharmaceuticals in the NASDAQ 100?
  • Is Corvus Pharmaceuticals in the Dow Jones?
  • When was Corvus Pharmaceuticals's last earnings report?
  • When does Corvus Pharmaceuticals report earnings?
  • Should I buy Corvus Pharmaceuticals stock now?

What is the ticker symbol for Corvus Pharmaceuticals?

The ticker symbol for Corvus Pharmaceuticals is NASDAQ:CRVS

Does Corvus Pharmaceuticals pay dividends?

No, Corvus Pharmaceuticals does not pay dividends

What sector is Corvus Pharmaceuticals in?

Corvus Pharmaceuticals is in the Healthcare sector

What industry is Corvus Pharmaceuticals in?

Corvus Pharmaceuticals is in the Biotechnology industry

What country is Corvus Pharmaceuticals based in?

Corvus Pharmaceuticals is headquartered in United States

When did Corvus Pharmaceuticals go public?

Corvus Pharmaceuticals's initial public offering (IPO) was on March 23, 2016

Is Corvus Pharmaceuticals in the S&P 500?

No, Corvus Pharmaceuticals is not included in the S&P 500 index

Is Corvus Pharmaceuticals in the NASDAQ 100?

No, Corvus Pharmaceuticals is not included in the NASDAQ 100 index

Is Corvus Pharmaceuticals in the Dow Jones?

No, Corvus Pharmaceuticals is not included in the Dow Jones index

When was Corvus Pharmaceuticals's last earnings report?

Corvus Pharmaceuticals's most recent earnings report was on Nov 12, 2024

When does Corvus Pharmaceuticals report earnings?

The next expected earnings date for Corvus Pharmaceuticals is Mar 19, 2025

Should I buy Corvus Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions